| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |